Trials / Completed
CompletedNCT00682643
A Clinical Study With Fluticasone Furoate Nasal Spray And Vehicle Placebo For The Treatment Of Perennial (Year-round) Allergic Rhinitis
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter, Two-Year Study to Evaluate the Ocular Safety of Once-Daily, Fluticasone Furoate Nasal Spray 110mcg in Adults and Adolescents 12 Years of Age and Older With Perennial Allergic Rhinitis
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 550 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess long-term ocular safety of fluticasone furoate nasal spray in adult and adolescent subjects diagnosed with perennial allergic rhinitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fluticasone furoate nasal spray | fluticasone furoate nasal spray |
| DRUG | vehicle placebo nasal spray | placebo |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2011-02-01
- Completion
- 2011-02-01
- First posted
- 2008-05-22
- Last updated
- 2017-01-13
- Results posted
- 2012-03-13
Locations
56 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00682643. Inclusion in this directory is not an endorsement.